International Stem Cell Corp banner

International Stem Cell Corp
OTC:ISCO

Watchlist Manager
International Stem Cell Corp Logo
International Stem Cell Corp
OTC:ISCO
Watchlist
Price: 0.17 USD Market Closed
Market Cap: $1.4m

During the last 3 months International Stem Cell Corp insiders have not bought any shares, and have not sold any shares.

The last transaction was made on Apr 18, 2019 by Maier Paul V , who sold 1.7k USD worth of ISCO shares.

Last Transactions:
Maier Paul V
$-1.7k
Semechkin Andrey
$+1m
Garnette Sophia
$-14.7k
Garnette Sophia
$-1.7k
Garnette Sophia
$-4.5k
Garnette Sophia
$-318
Garnette Sophia
$-1.9k
Don Wright
$-6k
Don Wright
$-399
Don Wright
$-3.9k
Don Wright
$-3.2k
Semechkin Andrey
$+3.3m
Don Wright
$-750
Don Wright
$-775
Semechkin Andrey
$+5.2k
Semechkin Andrey
$+5.1k
Semechkin Andrey
$+800
Semechkin Andrey
$+10.8k
Semechkin Andrey
$+3.3k
Semechkin Andrey
$+1.5k
Semechkin Andrey
$+6.6k
Semechkin Andrey
$+500k
Semechkin Andrey
$+350k
Semechkin Andrey
$+270k
Semechkin Andrey
$+376.3k
Semechkin Andrey
$+4.3m
View All Transactions

During the last 3 months International Stem Cell Corp insiders have not bought any shares, and have not sold any shares.

The last transaction was made on Apr 18, 2019 by Maier Paul V , who sold 1.7k USD worth of ISCO shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

International Stem Cell Corp
Insider Trading Chart

International Stem Cell Corp
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

International Stem Cell Corp
Last Insider Transactions

Global
Insiders Monitor

International Stem Cell Corp
Glance View

Market Cap
1.4m USD
Industry
Biotechnology

International Stem Cell Corp. operates as a clinical stage biotechnology company. The company is headquartered in Carlsbad, California. The company went IPO on 2006-09-25. The firm is focused on therapeutic and biomedical product development. The firm's segments include therapeutic market, anti-aging market and biomedical market. The firm is primarily a research and development company, for the therapeutic market, which is focused on clinical applications of human parthenogenetic stem cells (hpSCs) for the treatment of various diseases of the central nervous system and liver diseases. The firm's subsidiaries include Lifeline Cell Technology, LLC (LCT), which develops, manufactures and commercializes primary human cell research products for the biomedical market; Lifeline Skin Care, Inc. (LSC) that develops, manufactures and markets a category of anti-aging skin care products for anti-aging market, and Cyto Therapeutics Pty. Ltd. (Cyto Therapeutics) performs research and development (R&D) for the therapeutic market.

ISCO Intrinsic Value
0.78 USD
Undervaluation 78%
Intrinsic Value
Price

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett